Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?

References

• Conus P, McGorry P D. First episode mania—a neglected priority for early intervention. Australian and New Zealand Journal of Psychiatry 2002; 36: 158–172
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in referred children and younger siblings of manic depressives. Mode of onset and prospective course. Archives of General Psychiatry 1985; 42: 996–1003
   PubMed Web of Science ®Google Scholar
• APA. Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 2002; 159: 4–50
   Web of Science ®Google Scholar
• Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month randomized double-blind, controlled clinical trial. American Journal of Psychiatry 2005; 162: 1281–1290
   PubMed Web of Science ®Google Scholar
• Tohen M, Marneros A, Bowden CL, Greil W, Koukopoulos A, Belmaker H, Jacobs T, Baker RW, Wiliamson D, Evans AR, Dossenbach M, Cassano G. Olanzapine vs. Lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Bipolar Disorders 2003; 5(Suppl 1)89
   Google Scholar
• Tohen M, Bowden CL, Calabrese JR, Chou JC, Jacobs T, Baker RW, Williamson Evans R. Olanzapine's efficacy for relapse prevention in bipolar disorder: a randomized double-blind placebo-controlled 12-month clinical trial. Bipolar Disorders 2003; 5(Suppl 1)89
   Google Scholar
• Tohen M, Chengappa K, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. Mood stabiliser alone. British Journal of Psychiatry 2004; 184: 337–345
   PubMed Web of Science ®Google Scholar
• Lambert M, Conus P, Lambert T, McGorry PD. Pharmacotherapy of first-episode psychosis. Expert Opinion on Pharmacotherapy 2003; 4: 717–750
   PubMed Web of Science ®Google Scholar
• The National Early Psychosis Project (NEPP). Australian guidelines for early psychosis. University of Melbourne, Melbourne 1998
   Google Scholar
• Royal Australian & New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry 2005; 39: 1–30
   Google Scholar
• Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. British Journal of Psychiatry 2005; 187(Suppl. 48)s120–s124
   Google Scholar
• Zarate CA, Jr., Tohen M. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. Journal of Clinical Psychiatry 2000; 61: 33–38
   PubMed Web of Science ®Google Scholar
• Tohen M, Zarate CA, Jr., Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. American Journal of Psychiatry 2003; 160: 2099–2107
   PubMed Web of Science ®Google Scholar
• Craig TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, Bromet EJ. Medication use patterns and 2-year outcome in first-admission bipolar disorders with psychotic features. Bipolar Disorders 2004; 6: 406–415
   PubMed Web of Science ®Google Scholar
• Lambert M, Conus P, Lubmann DI, Wade D, Yuen HP, Eide P, Moritz S, Naber D, McGorry PD, Schimmelmann BG. The impact of substance abuse disorder on clinical outcome in 643 patients with first episode psychosis. Acta Psychiatrica Scandinavica 2005; 112: 141–148
   PubMed Web of Science ®Google Scholar
• Samellas D, Read P, Cookson JC. Antipsychotic drugs in mania: factors predicting use of antipsychotic medication following inpatient treatment of mania. International Clinical Psychopharmacology 2004; 19: 291–297
   PubMed Web of Science ®Google Scholar
• Egeland JA, Blumenthal RL, Nee J, Sharpe L, Eddincott J. Reliability and relationship of various ages of onset criteria for major affective disorders. Journal of Affective Disorders 1987; 12: 159–165
   PubMed Web of Science ®Google Scholar
• Baethege C, Smolka MN, Grushka P, Berghöfer A, Schlattmann P, Bauer M, Atshuler L, Grof P, Müller-Oerlinghausen B. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatrica Scandinavica 2003; 107: 260–267
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Altshuler L, Frye MA, Suppes TM, Keck PE, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disorders 2003; 5: 310–319
   PubMed Web of Science ®Google Scholar
• Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. Journal of Affective Disorders 1994; 31: 281–294
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Hantouche EG, Azorin JM, Lancrenon S, Châtenent-Duchêene L, Allilaire JF. Clinical characterization acute mania: data in 1090 patients—“EPIMAN-II”. Bipolar Disorders 2003; 5(Suppl 1)27
   Google Scholar
• Wozniak J, Biederman J, Richards JA. Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. Journal of Clinical Psychiatry 2001; 62(Suppl 14)10–15
   PubMed Web of Science ®Google Scholar
• Joyce PR. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychological Medicine 1984; 14: 145–149
   PubMed Web of Science ®Google Scholar
• McGlashan TH. Adolescent versus adult onset of mania. American Journal of Psychiatry 1988; 145: 221–223
   PubMed Web of Science ®Google Scholar
• Conus P, Abdel-Baki A, Harrigan S, Lambert M, McGorry PD. Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. Journal of Affective Disorders 2004; 81: 259–268
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Treatment latency and previous episodes: relationship to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disorders 2003; 5: 169–179
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. Journal of Clinical Psychiatry 2002; 63: 985–991
   PubMed Web of Science ®Google Scholar
• Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry 1992; 149: 999–1010
   PubMed Web of Science ®Google Scholar
• MacNeil CA, Conus P, Kader LF, Berk M, Eide P, Lucas N, Hasty MK, Allen N. Presented at the 4th International Conference on Early Psychosis., Vancouver, 28th Sept—1st Oct, 2004, Cognitive Behavioural Therapy with Bipolar Disorder—Challenges and opportunities with a first-episode population
   Google Scholar
• Hennion JP, el-Masri MA, Huff MO, el-Mailakh RS. Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage. Bipolar Disorders 2002; 4: 201–206
   PubMed Web of Science ®Google Scholar
• Monkul ES, Malhi GS, Soares JC. Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?. Australian and New Zealand Journal of Psychiatry 2005; 39: 222–226
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M, HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 2005; 62: 361–370
   PubMed Web of Science ®Google Scholar
• Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A. Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. American Academy of Child and Adolescent Psychiatry 2005; 44: 565–573
   PubMed Web of Science ®Google Scholar
• Keck PE, McElroy SL, Strakowski SM. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. Journal of Clinical Psychiatry 2000; 61(Suppl 4)33–38
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th edn. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Mensink GJR, Sloof CJ. Novel antipsychotics in bipolar and schizoaffective mania. Acta Psychiatrica Scandinavica 2004; 109: 405–419
   PubMed Web of Science ®Google Scholar
• Mahli GS, Berk M, Bourin M, Ivanovski B, Dodd S, Lagopoulos J, Mitchell PB. Atypical mood stabilizers: a “typical role for atypical antipsychotics. Acta Psychiatrica Scandinavica 2005; 111(Suppl 426)29–38
   PubMed Web of Science ®Google Scholar
• Basco MR, Rush AJ. Compliance with pharmacology in mood disorders. Psychiatric Annals 1995; 25: 269–279
   Web of Science ®Google Scholar
• Keck PE, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA. Factors associated with pharmacological noncompliance in patients with mania. Journal of Clinical Psychiatry 1996; 57: 292–297
   PubMed Web of Science ®Google Scholar
• Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P. 12-month outcome of patients with bipolar disorder following hospitalisation for a manic or mixed episode. American Journal of Psychiatry 1998; 155: 646–652
   PubMed Web of Science ®Google Scholar
• Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consult Clinical Psychology 1984; 52: 873–878
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Keck PE, McElroy SL, West SA, Sax KW, Hawkins JM, Kmetz GF, Upadhyaya VH, Tugrul KC, Bourne ML. Twelve-month outcome after first hospitalisation for affective psychosis. Archives of General Psychiatry 1998; 55: 49–55
   PubMed Web of Science ®Google Scholar
• MacNeil C. Cognitive behavioural therapy with bipolar disorder—theory and reality with a first episode population. Schizophrenia Research 2004; 70(Suppl 1)92
   Web of Science ®Google Scholar
• Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in the referred children and younger siblings of manic-depressives: mode of onset and prospective course. Archives of General Psychiatry 1985; 42: 996–1003
   PubMed Web of Science ®Google Scholar
• Egeland JA, Hostetter AM, Pauls DL, Sussex JN. Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. Journal of the American Academy of Child and Adolescent Psychiatry 2000; 39: 1245–1252
   PubMed Web of Science ®Google Scholar
• Thompson KN, Conus P, Ward JL, Phillips LJ, Koutsogiannis J, Leicester S, McGorry PD. The initial prodrome to bipolar affective disorder: prospective case studies. Journal of Affective Disorder 2003; 77: 79–85
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia Research 2003; 60: 21–32
   PubMed Web of Science ®Google Scholar
• Ward JL, Berk M, Lucas N, Macneil C, Hasty MK, Kader LF, Conus P, Allen N, Yung A, McGorry PD. The prodromal presentation of a first episode mania cohort. Bipolar Disorders 2005; 7(Suppl 2)111
   PubMed Web of Science ®Google Scholar
• Perugi G, Micheli C, Akiskal HS, Madaro D, Socci C, Quilici C, Musetti L. Polarity of the first episode clinical characteristics and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Comprehensive Psychiatry 2000; 41: 13–18
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 2002; 59: 530–537
   PubMed Web of Science ®Google Scholar
• Berk M, Dodd S. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolardepression?. Medical Hypotheses 2005; 65: 39–43
   PubMed Web of Science ®Google Scholar
• Geller B, Tillman R, Craney JL, Bolhofner K. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry 2004; 61: 459–467
   PubMed Web of Science ®Google Scholar
• Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical genetic and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Archives of General Psychiatry 1982; 39: 549–555
   PubMed Web of Science ®Google Scholar
• Berk M, Malhi GS, Mitchell PB, Cahill CM, Carman AC, Hadzi-Pavlovic D, Hawkins MT, Tohen M. Scale matters: the need for a bipolar depression rating scale (BDRS). Acta Psychiatrica Scandinavica 2004; 422: 39–45
   Google Scholar
• Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE, Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD. Screening for bipolar disorder in the community. Journal of Clinical Psychiatry 2003; 64: 53–59
   PubMed Web of Science ®Google Scholar
• Malla AM, Norman RM. Treating psychosis: is there more to early intervention than intervening early?. Canadian Journal of Psychiatry 2001; 46: 645–648
   PubMed Web of Science ®Google Scholar
• McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry 2002; 1: 76–83
   PubMedGoogle Scholar
• Guy W. ECDEU assessment manual for psychopharmacology revised. DHEW Pub. No. (ADM) 76–338. National Institute of Mental Health, Rockville, MD 1976
   Google Scholar
• Lambert M, Conus P, Eide P, Ward J, Yuen HP, McGorry P. Treatment of Early Psychosis with Olanzapine or Risperidone (TEPOR study)-A medical record review study in 367 non-affective and affective first-episode psychosis patients admitted to the Early Psychosis Prevention and Intervention Centre (EPPIC) in Melbourne Australia between 1998–2000. Pharmacopsychiatry 2005; 38: 1–8
   PubMed Web of Science ®Google Scholar
• Conus P, Cotton S, Abdel-Baki A, McGorry PD. First episode psychotic mania: 12 month outcome in an epidemiological catchment area sample. European Psychiatry 2004; 19(Suppl 1)37
   Google Scholar